Breaking News
October 16, 2018 - New research identifies modifiable dementia risk factor in elderly people
October 16, 2018 - Zebrafish study uncovers molecular ‘brake’ that helps control eye lens development
October 16, 2018 - Overlapping copy number variations underlie autism and schizophrenia in Japanese patients
October 16, 2018 - Majority of Americans’ ancestry can be traced through existing DNA databases
October 16, 2018 - Patients coerced into mental health care less likely to perceive treatment as effective
October 16, 2018 - What you need to know about autism spectrum disorder
October 16, 2018 - Antidepressants can be used to treat Alzheimer’s disease
October 16, 2018 - Study uncovers important role of PRMT1 in dilated cardiomyopathy
October 16, 2018 - Nutritional quality of breakfast linked to cardiovascular and metabolic risk factors in children
October 16, 2018 - Study uses novel approach to investigate genetic origins of mental illnesses
October 16, 2018 - Scientists develop dual anthrax-plague vaccine
October 16, 2018 - Poor Outcomes for Hispanic Infants With Congenital Heart Dz
October 16, 2018 - Global study finds youngest in class more likely to be diagnosed with ADHD
October 16, 2018 - Researchers sequence two selfish genes in the fungus Neurospora intermedia
October 16, 2018 - Survey results highlight the need for better communication between patients and HCPs about bacterial vaginosis
October 16, 2018 - Researchers develop fibrin-targeting immunotherapy to protect against neurodegeneration
October 16, 2018 - Researchers create open access database on healthy immunity
October 16, 2018 - Rice University chemist wins big award to study small surfaces
October 16, 2018 - Study finds 43% drop in stroke rate
October 16, 2018 - Researchers identify basic relationships of cell cycle and cellular senescence in the placenta
October 16, 2018 - UA professor receives NSF grant to develop antifouling materials for medical implants
October 16, 2018 - Obesity Doubles Odds for Colon Cancer in Younger Women
October 16, 2018 - Adults with ADHD not constrained in creativity
October 16, 2018 - Raising visibility for people and students with chronic illness and disability
October 16, 2018 - Allele awarded NIH grant to develop nanoantibody therapies for treatment of sepsis
October 16, 2018 - Only 59% of young adults undergoing surgery are fluid responsive
October 16, 2018 - Research points to potential new treatment for hearing loss
October 16, 2018 - MDI Biological Laboratory receives $1.2 million SEPA grant to promote data literacy
October 16, 2018 - Vast majority of dementia cases may arise from spontaneous genetic errors
October 16, 2018 - New project aims to deliver fast, effective treatment for autoimmune rheumatic diseases
October 16, 2018 - Study identifies molecular switch that controls fate of milk-producing breast cells
October 16, 2018 - Research shows diet has little influence on precursor to gout
October 16, 2018 - “Without Dr. Shumway doing his miracle work, three generations would not be here”: A Stanford heart transplant patient’s story
October 16, 2018 - Non-invasive brain stimulation sheds light on neurobiology underlying implicit bias
October 16, 2018 - Researchers demonstrate integrated technique to control production of cell therapeutics
October 16, 2018 - Breast tomosynthesis detects 34% more tumors than traditional mammography
October 16, 2018 - Rhode Island Hospital, Brown receive $800,000 grant to keep up fight against opioid epidemic
October 16, 2018 - UVA partners with health systems in AVIA network’s Medicaid Transformation Project
October 16, 2018 - Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
October 16, 2018 - Study reveals early warning signs of heart problems in patients with newly diagnosed lupus
October 16, 2018 - Connecting the dots of Alzheimer’s disease
October 16, 2018 - New publication offers evidence-based content for global breast imaging medical community
October 16, 2018 - ‘EinsteinVision’ that improves hand-eye coordination of surgeons introduced at Harefield Hospital
October 16, 2018 - WRAIR clinical study evaluates safety and immunogenicity of Marburg vaccine
October 16, 2018 - Ketamine can be considered as alternative to opioids for short-term pain control in ED
October 16, 2018 - Endurance exercise training beneficially alters gut microbiota composition
October 15, 2018 - FDA Approves Yutiq (fluocinolone acetonide intravitreal implant) for Chronic Non-Infectious Posterior Segment Uveitis
October 15, 2018 - Birthing Options for Full-Term Pregnancy
October 15, 2018 - Stressed, toxic, zombie cells seen for first time in Alzheimer’s
October 15, 2018 - Concussion researchers study head motion in high school football hits | News Center
October 15, 2018 - Neuropsychiatric symptoms related to earliest stages of Alzheimer’s brain pathology
October 15, 2018 - Neck collar device may help protect the brain of female high school soccer players
October 15, 2018 - Research reveals how the inner ear processes speech
October 15, 2018 - Many parents still skeptical about safety and effectiveness of flu shot, survey finds
October 15, 2018 - Payer Policies May Discourage Non-Pharma Tx for Low Back Pain
October 15, 2018 - Exercise may delay cognitive decline in people with rare Alzheimer’s disease
October 15, 2018 - Researchers modify CRISPR to reorganize genome | News Center
October 15, 2018 - Innovative brain tumor operation set to tailor to patients’ needs
October 15, 2018 - Findings offer new insight into early changes that occur during AD pathology
October 15, 2018 - Neurons regulating reproductive hormone release have different activity in epileptic mice
October 15, 2018 - More parents are concerned about taking babies swimming in public pools
October 15, 2018 - Health Tip: Know the Risk Factors for Lower Back Pain
October 15, 2018 - Study shows cigarillo flavors enhanced by high-intensity sweeteners
October 15, 2018 - Study traces hospital-acquired bloodstream infections to patients’ own bodies | News Center
October 15, 2018 - Abnormal vision in childhood can affect development of brain areas responsible for attention
October 15, 2018 - Study highlights need for increased support for alcohol-related liver disease patients
October 15, 2018 - Color-changing contact lens could help doctors to monitor eye disease medications
October 15, 2018 - Tobacco heating products cause less staining to teeth than conventional cigarettes
October 15, 2018 - Young adults who are obese can expect to lose up to 10 years in life expectancy
October 15, 2018 - Scientists uncover how proteins meet on the cell membrane
October 15, 2018 - Affordable housing with supportive social services for senior citizens can reduce hospital use
October 15, 2018 - Schiller Easy Pulse Saves Lives
October 15, 2018 - The latest ECG device from Schiller
October 15, 2018 - Following a Tissue Sample
October 15, 2018 - Prisoners need drug and alcohol treatments but AA programs aren’t the answer
October 15, 2018 - Andrea Califano and Jordan Orange Elected to National Academy of Medicine
October 15, 2018 - The impending risk of African Swine Fever Virus
October 15, 2018 - Breastfeeding reduces the number of antibiotic-resistant bacteria in infant gut
October 15, 2018 - Researchers develop comprehensive molecular atlas of postnatal mouse heart development
October 15, 2018 - ObsEva SA Presents Clinical Data from Phase III IMPLANT 2 Trial of Nolasiban in IVF at the American Society of Reproductive Medicine (ASRM) Annual Meeting
Horwitz Prize Awarded for Work on Hormones

Horwitz Prize Awarded for Work on Hormones

image_pdfDownload PDFimage_print

Columbia University will award the 2018 Louisa Gross Horwitz Prize to three scientists:

Pierre Chambon, Institute of Advanced Study at the Strasbourg University and Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Strasbourg, France

Ronald M. Evans, Salk Institute, La Jolla, Calif., and Howard Hughes Medical Institute, Chevy Chase, Md.

Bert W. O’Malley, Baylor College of Medicine, Houston, Texas

“for their discoveries of how steroid hormones regulate the behavior of distant cells.”

From left: Pierre Chambon, Ronald M. Evans, and Bert W. O’Malley

If you open up your medicine cabinet, it’s a safe bet that you’ll find a drug that targets a nuclear hormone receptor. Columbia University awards the 2018 Louisa Gross Horwitz Prize to Pierre Chambon, Ronald M. Evans, and Bert W. O’Malley for their research—spanning over 50 years—decoding how steroid hormones and nuclear receptors regulate cell function. This work has transformed our understanding of human physiology and disease.

Steroid hormones like cortisol and estrogens were first identified in the early 1900s. Researchers observed that these chemicals could travel long distances from one organ to another and that they influenced a wide variety of biological processes, including development, reproduction, growth, metabolism, and inflammation. But just how hormones worked remained a mystery for decades.

When molecular biology techniques became available in the 1960s, scientists could finally begin to more precisely probe the mechanism by which hormones act. Using these tools, O’Malley’s laboratory demonstrated that steroid hormones modify gene expression. This was a paradigm shift because until then many researchers thought that hormones worked by directly interacting with enzymes or manipulating the cell membrane. In a series of papers published between 1967 and 1972, O’Malley’s team showed that steroid hormones enter the cell and bind to nuclear receptors, a specialized protein that enters the nucleus and modifies gene activity. This tinkering of gene expression triggers biological changes in the cell and physiological changes in the body.

In the 1980s, scientists built on this work and isolated the genes that code for steroid hormone receptors. Teams led by Chambon and Evans were the first to discover and clone the genes for estrogen and cortisol receptors, respectively. Previously, researchers had predicted that the number of nuclear receptors would be small. But one of the big surprises that came from comparing the sequences of these nuclear receptors was that there were dozens of similar genes.

The laboratories of Chambon and Evans, in conjunction with others, proceeded to identify and isolate many of these related genes, mapping out a “superfamily” of 48 human nuclear receptors that collectively regulate a wide array of biological processes. Some of the genes they discovered had no hormone associated with them, and so were named “orphan receptors.” This work opened up a new field of biology and showed that a variety of molecules—not just steroid hormones, but thyroid hormones, bile acids, fatty acids, and others—could also bind to nuclear receptors to regulate the gene expression of cells over great distances in the body.

Following these seminal discoveries, subsequent work by all three scientists has continued to add important details to the molecule-by-molecule picture of how the 10 trillion cells in our body communicate with each other and stay in functional harmony. Unraveling these mysteries has given us deeper insight into the pathways that lead to a variety of human diseases. Today, drugs targeting nuclear receptors comprise 13 percent of all U.S. FDA-approved pharmaceuticals. These drugs treat everything from the most commonplace to the most serious conditions—including over-the-counter topical cortisone for skin inflammation, prescription rosiglitazone for type 2 diabetes, and tamoxifen, the most widely used cancer drug in the world.

Our ability to treat such a diverse array of diseases began with scientists who connected the dots among hormone, receptor, and gene.

A nuclear receptor complex binding to DNA. Credit: Protein Data Bank (2NLL)

Comments from Committee Chair 

Gerard Karsenty, MD, PhD, chair of the Horwitz Prize Committee and chair of the Department of Genetics & Development at Columbia University Vagelos College of Physicians and Surgeons:

“Nuclear receptors are a Rosetta Stone for physiology; their discovery and characterization helped solved mysteries about many of our most fundamental biological processes that were first unearthed nearly a century ago. The work of these three scientists has profoundly transformed our understanding of the human body and how we treat a wide range of diseases.”

  

Awardee Biographies

Pierre Chambon, MD, is professor of molecular genetics at the Institute of Advanced Study of the University of Strasbourg and group leader at the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Strasbourg, France, emeritus professor at the Collège de France (Paris), and emeritus professor at the Faculty of Medicine of the Strasbourg University. Dr. Chambon completed his MD at the University of Strasbourg in 1958. Dr. Chambon also won the Horwitz prize in 1999 for his work in understanding the transcription of genetic material into messenger RNA. 

Ronald M. Evans, PhD, is a Howard Hughes Medical Institute investigator and professor at the Salk Institute in La Jolla, Calif. Dr. Evans received his bachelor’s degree in 1959 and completed his PhD in microbiology in 1963, both at the University of California, Los Angeles.

Bert W. O’Malley, MD, is the T.C.Thompson Distinguished Leadership Professor of Molecular and Cellular Biology and Chancellor at Baylor College of Medicine in Houston, Texas. Dr. O’Malley received his bachelor’s and medical degrees from the University of Pittsburgh in 1959 and 1963, respectively.

 

Press Contact 

Lucky Tran, PhD, +1 212-305-3689, lucky.tran@columbia.edu

 

The Louisa Gross Horwitz Prize

The Louisa Gross Horwitz Prize was established under the will of the late S. Gross Horwitz through a bequest to Columbia University. It is named in honor of the donor’s mother, Louisa Gross Horwitz, who was the daughter of Dr. Samuel David Gross (1805–89), a prominent Philadelphia surgeon who served as president of the American Medical Association and wrote “Systems of Surgery.” Of the 95 Horwitz Prize winners to date, 43 have gone on to receive Nobel Prizes. Most recently, the 2013 Horwitz Prize winners, Edvard I. Moser, PhD, and May-Britt Moser, PhD, of the Norwegian University of Science and Technology in Norway, shared the 2014 Nobel Prize in Physiology or Medicine with John Michael O’Keefe, PhD, of University College London. For a list of previous Horwitz Prize awardees, please click here.

The 2018 Louisa Gross Horwitz Prize Lectures will be held on Monday, Oct. 29, 2018, followed by an awards ceremony.

For more information about the Louisa Gross Horwitz Prize and the lectures, please visit http://www.cumc.columbia.edu/research/horwitz-prize.

 

Columbia University Irving Medical Center

Columbia University Irving Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the Vagelos College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. The campus that Columbia University Medical Center shares with its hospital partner, NewYork-Presbyterian, is now called the Columbia University Irving Medical Center.  For more information, visit cumc.columbia.edu or columbiadoctors.org.

Tagged with:

About author

Related Articles